PCSK9 deficiency is strongly linked to the development of cardiomyopathy, characterised by impaired mitochondrial oxidative capacity, altered substrate utilisation, and deteriorated contractile function [115]. This evidence concerns the gene PCSK9 and cardiomyopathy.